Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Michelle M MitchenerAntimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.ORCID 0000-0001-5036-2286
Caleb M AndersonDepartment of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID 0000-0003-3395-7805
Mark VelebaSingapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Singapore.
Kayla TeoAntimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.
Mélanie RochDepartment of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID 0000-0001-6485-8434
Ruixi ChenDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Yifeng YuanDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Isaiah HanAntimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.
Agnieszka DziergowskaInstitute of Organic Chemistry, Lodz University of Technology, Lodz, Poland.
Kevin PetheAntimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.ORCID 0000-0003-0916-8873
Thomas J BegleyDepartment of Biological Sciences, University at Albany, Albany, New York, USA.
Kimberly A KlineAntimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.ORCID 0000-0002-5472-3074
Peter C DedonAntimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.ORCID 0000-0003-0011-3067
Funding
Ministry of Health -Singapore MOH-000645National Research Foundation Singapore CREATE SMART AMR IRGNational Research Foundation Singapore SCELSENIH HHS R01GM143749, R01ES026856Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 219227Societe Acadmique de Geneve
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Growth-dependent tRNA reprogramming and codon bias link translation to metabolic state in · full record | OpenQuestion